Click here
to receive an email alert any time IN VIVO publishes a quarterly review on device/diagnostics dealmaking.
Device companies kicked off 2013 by raising $1.1 billion via 45 transactions; the only device M&A transaction in Q1 to exceed the billion-dollar mark was Cardinal Health Inc.’s $2.07 billion acquisition of AssuraMed. Diagnostics firms began 2013 by raising a total of $286 million in the opening quarter, a 46% improvement over Q4 2012’s tally.
Click here
to receive an email alert any time IN VIVO publishes a quarterly review on device/diagnostics dealmaking.